Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Taraneh Mousavi, Shekoufeh Nikfar & Mohammad Abdollahi. (2023) An update on the use of pharmacotherapy for opioid-induced bowel dysfunction. Expert Opinion on Pharmacotherapy 24:3, pages 359-375.
Read now
Read now
Per M. Hellström & Ahmad Al-Saffar. (2018) Gastroparesis: pharmacotherapy and cardiac risk. Scandinavian Journal of Gastroenterology 53:5, pages 513-518.
Read now
Read now
Stephanie C Yoon & Heather C Bruner. (2017) Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem. Patient Preference and Adherence 11, pages 1265-1271.
Read now
Read now
Blanca Serrano-Falcón & Enrique Rey. (2017) The safety of available treatments for chronic constipation. Expert Opinion on Drug Safety 16:11, pages 1243-1253.
Read now
Read now
Waldemar Siemens & Gerhild Becker. (2016) Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes. Therapeutics and Clinical Risk Management 12, pages 401-412.
Read now
Read now
Heather C Bruner, Rabia S Atayee, Kyle P Edmonds & Gary T Buckholz. (2015) Clinical utility of naloxegol in the treatment of opioid-induced constipation. Journal of Pain Research 8, pages 289-294.
Read now
Read now
Guido Fanelli & Andrea Fanelli. (2015) Developments in managing severe chronic pain: role of oxycodone–naloxone extended release. Drug Design, Development and Therapy 9, pages 3811-3816.
Read now
Read now
Articles from other publishers (5)
Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Mitsuru Sandoh, Satoshi Takei, Kazuya Arai, Hiromi Nishiba, Junnosuke Mogi, Kyoichi Kaira & Koichi Minato. (2022) A retrospective study of the efficacy and safety of naldemedine for opioid‐induced constipation in thoracic cancer patients. Thoracic Cancer 13:16, pages 2301-2308.
Crossref
Crossref
Cecilie Siggaard Knoph, Mathias Ellgaard Cook, Camilla Ann Fjelsted, Srdan Novovic, Michael Bau Mortensen, Liv Bjerre Juul Nielsen, Mark Berner Hansen, Jens Brøndum Frøkjær, Søren Schou Olesen & Asbjørn Mohr Drewes. (2021) Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial. Trials 22:1.
Crossref
Crossref
Helene Nordahl Christensen, Urban Olsson, Jesper From & Harald Breivik. (2016) Opioid-induced constipation, use of laxatives, and health-related quality of life. Scandinavian Journal of Pain 11:1, pages 104-110.
Crossref
Crossref
Asbjørn M. Drewes, Pia Munkholm, Magnus Simrén, Harald Breivik, Ulf E. Kongsgaard, Jan G. Hatlebakk, Lars Agreus, Maria Friedrichsen & Lona L. Christrup. (2016) Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction–Recommendations of the Nordic Working Group. Scandinavian Journal of Pain 11:1, pages 111-122.
Crossref
Crossref
Johan Ræder & Harald Breivik. (2015) Oral immediate and prolonged release oxycodone for safe and effective patient controlled analgesia after surgery Can opioid for acute postoperative pain be improved by adding a peripheral opioid antagonist?. Scandinavian Journal of Pain 7:1, pages 25-27.
Crossref
Crossref